What is transparency reporting in life sciences? How does it impact your compliance program? I recently had the opportunity to visit with Lucas Croteau, an innovator in the life sciences compliance sector, to explore these and other questions, highlighting the challenges, opportunities, and innovative solutions that are reshaping compliance practices in the life sciences sector today. (The full podcast is available here.) Croteau shared his journey and expertise in transparency reporting—a critical yet often overlooked component of life science compliance.
Lucas Croteau’s professional journey is nothing short of fascinating. With over a decade in consulting and eight years dedicated to compliance, Lucas has become a leading figure in transparency reporting. His initial foray into this niche area began at Medispend, a pioneer in software solutions for compliance. Over the years, Lucas noticed a significant gap: while many tools existed, the expertise to implement and manage transparency programs effectively was lacking. This realization led Lucas to found TracedData, a company dedicated to bridging the gap between technology and practical application. His mission? Compliance should be manageable and accessible, particularly for small to mid-sized life sciences companies.
Since 2010, the most recurring theme in all my compliance-related speeches, talks, and presentations has been the critical importance of documentation. As I often say, any compliance program’s three most important aspects are document, document, document. Croteau shares this sentiment, emphasizing that meticulous documentation is the backbone of any successful transparency program. It is not simply about meeting regulatory requirements but about creating an auditable, transparent system that can withstand scrutiny from regulators and business partners.
Croteau identified a market need for expert support in transparency reporting, especially for small to mid-sized companies, which need to be more significant to have a dedicated Chief Compliance Officer or corporate compliance function. These organizations often run lean compliance programs, requiring more internal resources to handle the complexities of transparency reporting. This is where TracedData steps in, offering a solution that is both cost-effective and comprehensive.
Croteau prefers “insourced” over “outsourced” to describe his approach. His team integrates seamlessly into client organizations, functioning as an extension of their staff. This model ensures compliance is a checkbox activity and a well-managed, ongoing process.
TracedData’s primary customers are small to mid-sized pharmaceutical, medical device, and biotech companies. These organizations often struggle to maintain robust compliance programs due to limited resources. For them, outsourcing transparency reporting to a specialized partner like TracedData provides significant value. It allows them to focus on their core business activities while ensuring compliance with regulatory requirements.
Croteau explained that many small—to mid-sized companies either need to help hire full-time compliance experts or delegate tasks to employees who lack the necessary expertise. TracedData fills this gap by offering specialized services at a fraction of the cost of an in-house team. Lucas and his team handle everything from data capture to report submission. They work closely with clients to build audit-ready programs, ensuring all documentation and regulatory requirements are in place. This comprehensive approach allows companies to achieve compliance without the associated stress and resource drain.
Artificial Intelligence (AI) is a hot topic in compliance, and for good reason. It has the potential to revolutionize how we manage and report data. Lucas sees AI as a significant opportunity in the life sciences sector, particularly for data monitoring and proactive risk mitigation. While AI is still emerging, its potential to streamline compliance processes and enhance accuracy is undeniable.
Croteau highlighted the work of Helio, a company at the forefront of AI in life sciences. They utilize AI to monitor data effectively, providing a glimpse into the future of compliance management. At TracedData, AI is already used to identify and correct misclassified transactions, demonstrating its practical benefits.
Compliance in the life sciences sector is not confined to the United States. Companies operating globally face myriad regulatory requirements, each with its own nuances. Lucas explained that transparency reporting varies significantly from country to country, making it a complex and ever-evolving challenge. Some companies build global reporting structures to manage this, while others handle compliance country-by-country. This tailored approach ensures that local regulations are met but also requires a deep understanding of each market’s requirements.
My conversation with Croteau underscored the importance of expertise, documentation, and innovative solutions in life sciences compliance. Companies must adapt as the regulatory landscape evolves by leveraging specialized partners and embracing new technologies like AI. For small to mid-sized companies, outsourcing transparency reporting to experts can provide the assurance and efficiency needed to thrive in this challenging environment.
